Niacin Reduces Atherosclerosis Development in APOE*3Leiden.CETP Mice Mainly by Reducing NonHDL-Cholesterol-Reference-Cited by-同舟云学术

Niacin Reduces Atherosclerosis Development in APOE*3Leiden.CETP Mice Mainly by Reducing NonHDL-Cholesterol

Published:2013-06-19 Issue:6 Volume:8 Page:e66467
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Kühnast Susan,Louwe Mieke C.,Heemskerk Mattijs M.,Pieterman Elsbet J.,van Klinken Jan B.,van den Berg Sjoerd A. A.,Smit Johannes W. A.,Havekes Louis M.,Rensen Patrick C. N.,van der Hoorn José W. A.,Princen Hans M. G.,Jukema J. Wouter

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference46 articles.

1. Nicotinic acid: the broad-spectrum lipid drug. A 50th anniversary review;LA Carlson;J Intern Med,2005

2. Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: a meta-analysis of randomized controlled trials;RS Birjmohun;J Am Coll Cardiol,2005

3. Extended-release niacin or ezetimibe and carotid intima-media thickness;AJ Taylor;N Engl J Med,2009

4. Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins;AJ Taylor;Circulation,2004

5. The effect of 24 months of combination statin and extended-release niacin on carotid intima-media thickness: ARBITER 3;AJ Taylor;Curr Med Res Opin,2006

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatic transcript profiling in beef cattle: Effects of rumen-protected niacin supplementation;PLOS ONE;2023-08-03

2. Systematic analysis of the experimental and clinical pharmacology of nicotinamide and prospects for the treatment of atherosclerosis;Experimental and Clinical Gastroenterology;2023-01-18

3. An Ultrasound‐Responsive Theranostic Cyclodextrin‐Loaded Nanoparticle for Multimodal Imaging and Therapy for Atherosclerosis;Small;2022-06-16

4. Sirtuins in atherosclerosis: guardians of healthspan and therapeutic targets;Nature Reviews Cardiology;2022-03-30

5. NAD⁺ and Vascular Dysfunction: From Mechanisms to Therapeutic Opportunities;Journal of Lipid and Atherosclerosis;2022